Allergan, Inc.
(NYSE: AGN)
Basic Financial Information (AGN)
- Company Type
- Public (NYSE: AGN)
- Fiscal Year-End
- December
- Financial Filings
- US SEC
Annual Income Statements (AGN)
All amounts in millions of British Pounds except share amounts
| Year |
Revenue |
Gross Profit |
Operating Income |
Total Net Income |
Diluted EPS (Net Income) |
| Dec 08 |
3,041.0 |
2,515.3 |
585.5 |
578.6 |
1.31 |
| Dec 07 |
1,972.2 |
1,635.1 |
380.1 |
499.3 |
0.81 |
| Dec 06 |
1,563.5 |
1,269.7 |
20.8 |
(127.4) |
(0.22) |
View more detailed Annual Financials, including:- Income Statement, Balance Sheet, and Cash Flow
Quarterly Income Statements (AGN)
All amounts in millions of British Pounds except share amounts
| Year |
Revenue |
Gross Profit |
Operating Income |
Total Net Income |
Diluted EPS (Net Income) |
| Sep 09 |
716.9 |
597.4 |
157.1 |
179.0 |
0.36 |
| Jun 09* |
684.5 |
564.4 |
166.8 |
176.1 |
0.35 |
| Jun 09 |
684.5 |
564.4 |
166.8 |
176.1 |
0.35 |
| Mar 09 |
708.7 |
583.6 |
58.3 |
45.0 |
0.11 |
| Mar 09 |
708.7 |
583.6 |
58.3 |
45.0 |
0.11 |
View more detailed Quarterly Financials, including:- Income Statement, Balance Sheet, and Cash Flow
Stock Quote & Chart (F)
Comparison To Industry & Market (AGN)
| Valuation |
Company |
Industry1
|
Market2
|
| Price/Sales Ratio |
4.12 |
16.45 |
7.09 |
| Price/Earnings Ratio |
31.85 |
370.37 |
25.77 |
| Price/Book Ratio |
3.97 |
3.52 |
6.82 |
| Price/Cash Flow Ratio |
18.02 |
79.37 |
44.05 |
View more detailed Comparison Data, including:- Side-by-side comparison of Allergan and its top 3 competitors
Top Competitors (AGN)
| |
Allergan |
Alcon |
Bausch & Lomb |
Johnson & Johnson |
| Annual Sales |
2,676.8 |
3,825.9 |
1,519.8 |
38,751.8 |
| Employees |
8,740 |
15,400 |
13,000 |
118,700 |
| Market Cap (£ mil.) |
10,958.2 |
26,371.7 |
0.0 |
104,509.9 |
View Competitive Landscape, including:- Side-by-side comparisons of profitability, operations, and per share data
0.25
